Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 7;13(2):336.
doi: 10.3390/jcm13020336.

Radiomic Analysis in Pituitary Tumors: Current Knowledge and Future Perspectives

Affiliations
Review

Radiomic Analysis in Pituitary Tumors: Current Knowledge and Future Perspectives

Fabio Bioletto et al. J Clin Med. .

Abstract

Radiomic analysis has emerged as a valuable tool for extracting quantitative features from medical imaging data, providing in-depth insights into various contexts and diseases. By employing methods derived from advanced computational techniques, radiomics quantifies textural information through the evaluation of the spatial distribution of signal intensities and inter-voxel relationships. In recent years, these techniques have gained considerable attention also in the field of pituitary tumors, with promising results. Indeed, the extraction of radiomic features from pituitary magnetic resonance imaging (MRI) images has been shown to provide useful information on various relevant aspects of these diseases. Some of the key topics that have been explored in the existing literature include the association of radiomic parameters with histopathological and clinical data and their correlation with tumor invasiveness and aggressive behavior. Their prognostic value has also been evaluated, assessing their role in the prediction of post-surgical recurrence, response to medical treatments, and long-term outcomes. This review provides a comprehensive overview of the current knowledge and application of radiomics in pituitary tumors. It also examines the current limitations and future directions of radiomic analysis, highlighting the major challenges that need to be addressed before a consistent integration of these techniques into routine clinical practice.

Keywords: PitNET; consistency; histology; invasiveness; pituitary adenoma; pituitary tumor; radiomics; recurrence; treatment response.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
General description of the workflow that characterizes a radiomic study. Created with BioRender.com.

References

    1. Melmed S. Pituitary-Tumor Endocrinopathies. N. Engl. J. Med. 2020;382:937–950. doi: 10.1056/NEJMra1810772. - DOI - PubMed
    1. Bioletto F., Berton A.M., Prencipe N., Varaldo E., Bona C., Grottoli S. Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives. J. Clin. Med. 2022;11:6508. doi: 10.3390/jcm11216508. - DOI - PMC - PubMed
    1. Raverot G., Burman P., McCormack A., Heaney A., Petersenn S., Popovic V., Trouillas J., Dekkers O.M. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur. J. Endocrinol. 2018;178:G1–G24. doi: 10.1530/EJE-17-0796. - DOI - PubMed
    1. Berton A.M., Prencipe N., Bertero L., Baldi M., Bima C., Corsico M., Bianchi A., Mantovani G., Ferraù F., Sartorato P., et al. Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study. J. Clin. Med. 2023;12:25. doi: 10.3390/jcm12010025. - DOI - PMC - PubMed
    1. Smith K.A., Leever J.D., Chamoun R.B. Prediction of Consistency of Pituitary Adenomas by Magnetic Resonance Imaging. J. Neurol. Surg. Part B Skull Base. 2015;76:340–343. doi: 10.1055/s-0035-1549005. - DOI - PMC - PubMed

LinkOut - more resources